$NIO Inc(NIO.US)$4.775.. based on chart, should rebound by today, else latest tomoro…
Disclaimer: not an inducement to buy/sell

Operating as a telehealth company, $Hims & Hers Health(HIMS.US)$ connects patients with physicians through an app and automates medication fulfillment via its proprietary pharmacy facilities.
Here are the six key drivers influencing the company's growth:
1. Cost Advantage: $Hims & Hers Health(HIMS.US)$ provides treatments for a growing number of conditions at prices lower than typical insurance-covered costs. This cost efficiency creates a strong competitive moat...

$Hims & Hers Health(HIMS.US)$ has added GLP-1 weight-loss injections to its portfolio of products.
The injections will have the same active ingredient as $Novo-Nordisk A/S(NVO.US)$ ’s Ozempic and Wegovy.
HIMS stock is up by nearly 100% year-to-date.
Hims & Hers added that it would provide branded GLP-1 injections once supply catches up with demand. In the upcoming months, Hims & Hers will work towards providing access to compounded tirzepatide, whic...

$CAVA Group(CAVA.US)$ looks good hope to move

$SoundHound AI(SOUN.US)$ microsoft and NVIDA looking to purchase